Skip to main content
DEINOVE logo

DEINOVE — Investor Relations & Filings

Ticker · ALDEI ISIN · FR0010879056 LEI · 969500BEJSRFER0F2K08 PA Professional, scientific and technical activities
Open in API
Filings indexed 300 across all filing types
Latest filing 2017-05-23 Board/Management Inform…
Country FR France
Listing PA ALDEI

About DEINOVE

https://www.deinove.com

DEINOVE is a biotechnology company that discovers, develops, and produces high-value compounds derived from rare bacteria and microorganisms, often referred to as 'microbial dark matter'. Leveraging a proprietary technology platform, the company harnesses the metabolic potential of extremophilic bacteria, such as Deinococcus, to create innovative solutions. Its primary applications are focused on developing novel bio-based active ingredients, including carotenoids, for the cosmetics sector, and discovering new antibiotics to address the global challenge of antimicrobial resistance.

Recent filings

Filing Released Lang Actions
Communicated under the obligation to provide permanent information / Other communications
Board/Management Information Classification · 1% confidence The document is a press release dated May 23, 2017, announcing that Dr. Georges Gaudriault is joining DEINOVE as the new Director of Research and Development, replacing the previous incumbent. This announcement concerns a change in senior management personnel. Based on the provided definitions, the category 'Board/Management Information (Code: MANG)' is the most appropriate fit for announcements of changes in senior management.
2017-05-23 English
Communicated under the obligation to provide permanent information / Other communications
AGM Information Classification · 1% confidence The document is titled "SHAREHOLDERS' MEETING OF MAY 16, 2017: HERVÉ BRAILLY JOINS THE BOARD OF DIRECTORS" and explicitly states that DEINOVE's shareholders met at the Annual General Meeting (AGM) and voted on several resolutions, including the ratification of the appointment of Hervé Brailly as a new Director. While it mentions AGM results, the primary focus and headline are the board appointment, which falls under Board/Management Information (MANG). However, since the context is the official results and proceedings of the AGM itself, and it details the voting outcomes on various resolutions (including board appointments and capital structure changes), it strongly relates to the AGM event. Given the options, AGM-R (AGM Information) is the most appropriate fit as it covers presentations and materials shared during the AGM, which this document summarizes the key outcomes of. It is not just a management change announcement (MANG) because it is framed within the context of the AGM results.
2017-05-16 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
AGM Information Classification · 1% confidence The document is titled "Communiqué de presse" (Press Release) and announces the results of the Annual General Meeting (Assemblée générale annuelle ordinaire et extraordinaire) held on May 16, 2017. It details key shareholder votes (approving annual accounts, authorizing share buybacks, etc.) and specifically highlights the ratification of co-optations and the appointment of a new board member (Hervé Brailly). While it relates to the AGM, the primary focus is the announcement of governance changes and voting outcomes following the meeting, rather than being the AGM presentation itself (AGM-R) or a proxy solicitation document (PSI). The content strongly aligns with reporting on the results of shareholder votes and board changes. Since the document explicitly details the resolutions voted upon and the resulting board changes, it covers elements of both AGM results and Board/Management information. However, the core event is the AGM and the voting results are explicitly listed. The most specific category covering the results of shareholder votes is 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The appointment of a director is also a key outcome reported here, which overlaps with MANG, but the context is the formal AGM results announcement.
2017-05-16 French
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings Classification · 1% confidence The document is a press release dated May 10, 2017, announcing that DEINOVE's first patent focusing on animal nutrition has been issued in China. It details the patent's scope, the company's strategy in the animal nutrition market, and includes standard company boilerplate and contact information. This type of announcement, which is a specific corporate update (patent issuance) rather than a mandatory financial filing (like 10-K or IR) or a general regulatory notice (RNS), best fits the category for updates on financing, capital structure, or significant corporate actions that aren't explicitly covered elsewhere. Since it is not a standard financial report, earnings release, or management discussion, and it relates to intellectual property and market strategy, it is closest to a general corporate announcement. Given the provided options, it does not fit perfectly into the specific financial codes (10-K, IR, ER, DIV, etc.). It is an announcement of a significant corporate development (patent). If the patent relates to financing or capital structure, CAP might apply, but it's primarily IP news. If it were a general, non-specific regulatory filing, RNS would be the fallback. However, since it is a specific announcement about a corporate asset/development (a patent), and there is no specific 'Intellectual Property Announcement' code, the most appropriate general category for non-financial, non-management-change corporate news that isn't a standard report is the general Regulatory Filings/Announcements category (RNS), as it is a public disclosure of a material event.
2017-05-10 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is titled "Communiqué de presse" (Press Release) and announces a specific corporate event: the granting of a patent in China related to animal nutrition. It is a short announcement (3467 characters) detailing a single piece of news (a patent grant) and includes contact information for press and investors. This format strongly suggests a general corporate announcement rather than a detailed financial report (like 10-K or IR), a management discussion (MDA), or a specific regulatory filing like insider trading (DIRS) or dividend notice (DIV). Since it is a press release announcing a specific development (a patent), and it doesn't fit the definitions for ER, CT, or IP, the most appropriate general category for non-financial, non-meeting related corporate news that doesn't fit elsewhere is Regulatory Filings (RNS), which serves as a broad category for miscellaneous announcements.
2017-05-10 French
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings Classification · 1% confidence The document is explicitly titled '# Press Release' and details the successful completion of a project milestone ('The 2nd step of the project has been completed') and the commencement of the next phase, including future regulatory steps. It announces operational and R&D progress rather than releasing comprehensive periodic financial statements (like 10-K or IR) or formal voting results. This type of announcement, which communicates key business updates outside of mandatory periodic financial filings, is best classified as a general Regulatory Filing (RNS) or potentially an Earnings Release (ER) if it were tied to a specific reporting period's results. Since it focuses on a specific R&D project update and is formatted as a standard press release, RNS is the most appropriate general regulatory announcement category, as it doesn't fit the specific definitions for ER (which usually focuses on key financial metrics) or other specific event types.
2017-04-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.